Otlertuzumab
id:
otlertuzumab-244-15978735
title:
Otlertuzumab
text:
Otlertuzumab (TRU‐016) is a humanized monoclonal antibody that targets CD37 designed for the treatment of cancer. This drug was developed by Emergent BioSolutions and has been in clinical trials for lymphoma and Chronic Lymphocytic Leukemia (CLL)
brand slug:
wiki
category slug:
encyclopedia
description:
Monoclonal antibody
original url:
https://en.wikipedia.org/wiki/Otlertuzumab
date created:
date modified:
2023-09-26T14:18:51Z
main entity:
{"identifier":"Q15708277","url":"https://www.wikidata.org/entity/Q15708277"}
image:
fields total:
13
integrity:
14